[Systemic corticosteroids and their place in the management of hemorrhagic erysipelas].
BACKGROUND
Haemorrhagic erysipelas is a recently described clinical condition.


OBJECTIVE
Our aim is to study the clinical and evolutive particularities of haemorrhagic erysipelas treated with adjuvant corticotherapy.


METHODS
It's a retrospective study of 6 cases of erysipelas of the lower limbs with serious local signs (purpura, bullae, petechia).


RESULTS
Surgical examination as well as evaluation of muscular enzymes blood level were achieved in all cases. Adequate antibiotherapy and rapidly degressive systemic corticosteroids (0.5 mg/Kg daily) were prescribed. Fever, pain and cutaneous signs regressed rapidly. Haemorrhagic erysipelas is different from common erysipelas by the presence of serious local signs (bullae, purpura), by its bad response to adequate antibiotics and by its response to systemic steroids.
Ezzine Sebai
Nadia
N
Service dermatologie hôpital Charles Nicolle.
Hicheri
Jihene
J
Trojjet
Sondes
S
Khaled
Aida
A
Badri
Talel
T
Zeglaoui
Faten
F
Fezaa
Becima
B
Ridha Kamoun
Mohamed
M
D000328:Adult; D000368:Aged; D004886:Erysipelas / Q000150:complications / Q000188:drug therapy*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D035002:Lower Extremity; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D011446:Prospective Studies
D005938:Glucocorticoids; D011241:Prednisone